| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | | 660 mg | Exact identifier — unii+route 57 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | TABLET, DELAYED RELEASE / ORAL | | 640 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | POWDER, FOR SUSPENSION / ORAL | | 3 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION, EXTENDED RELEASE / ORAL | | 62 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / ORAL | | 3900 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | CAPSULE / ORAL | | 35 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | POWDER, FOR SOLUTION / ORAL | | 414 mg | Exact identifier — unii+route 54 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CONCENTRATE / ORAL | 0.04 mg/1ml | | Exact identifier — unii+route 66 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | POWDER, FOR SUSPENSION / ORAL | | 5010 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | SUSPENSION / ORAL | | 5013 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | CONCENTRATE / ORAL | | 104 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 0.02 mg | | Exact identifier — unii+route 66 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED / ORAL | NA | | Exact identifier — unii+route 66 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | TABLET, DELAYED RELEASE / ORAL | | 640 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / ORAL | | 46 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | TABLET, CHEWABLE / ORAL | | 14 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / ORAL | | 15 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | | Exact identifier — unii+route 57 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | ELIXIR / ORAL | | 90 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | | 160 mg | Exact identifier — unii+route 57 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, DELAYED RELEASE / ORAL | | 2 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SUSPENSION / ORAL | | 383 mg | Exact identifier — unii+route 54 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / ORAL | | 46 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SYRUP / ORAL | | 80 mg | Exact identifier — unii+route 54 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, EFFERVESCENT / ORAL | | 1080 mg | Exact identifier — unii+route 54 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SYRUP / ORAL | | 3 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| FD&C BLUE NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | LIQUID / ORAL | NA | | Exact identifier — unii+route+dosage form 3 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, LIQUID FILLED / ORAL | | 1 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, LIQUID FILLED / ORAL | | 1 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE, LIQUID FILLED / ORAL | | 360 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SOLUTION / ORAL | | 38 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | | 2400 mg | Exact identifier — unii+route+dosage form 3 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED PELLETS / ORAL | NA | | Exact identifier — unii+route 66 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | | 23 mg | Exact identifier — unii+route 57 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET / ORAL | | 7 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CONCENTRATE / ORAL | | 84 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | | 320 mg | Exact identifier — unii+route 57 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / ORAL | | 3900 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | ELIXIR / ORAL | | 120 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, ORALLY DISINTEGRATING / ORAL | | 60 mg | Exact identifier — unii+route 54 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | | Exact identifier — unii+route 57 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | | 23 mg | Exact identifier — unii+route 57 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED PELLETS / ORAL | NA | | Exact identifier — unii+route 66 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | LOZENGE / ORAL | | 115 mg | Exact identifier — unii+route 54 equally ranked IID candidates |
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / ORAL | | 29008 mg | Exact identifier — unii+route+dosage form 3 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | POWDER, FOR SOLUTION / ORAL | | 414 mg | Exact identifier — unii+route 54 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | TABLET, CHEWABLE / ORAL | | 14 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | POWDER, FOR SOLUTION / ORAL | 0.33 mg/5ml | | Exact identifier — unii+route 66 equally ranked IID candidates |
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | | 20 mg | Exact identifier — unii+route 57 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | LOZENGE / ORAL | | 115 mg | Exact identifier — unii+route 54 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | SYRUP / ORAL | | 705 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | GRANULE / ORAL | 5.4 mg | | Exact identifier — unii+route 54 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SOLUTION / ORAL | | 38 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, EXTENDED RELEASE / ORAL | 2.22 mg | | Exact identifier — unii+route 66 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SUSPENSION/ DROPS / ORAL | | 1 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE / ORAL | | 131 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| TRISODIUM CITRATE DIHYDRATE | TRISODIUM CITRATE DIHYDRATE | B22547B95K | CAPSULE / ORAL | | 35 mg | Exact identifier — unii+route 42 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | SUSPENSION, EXTENDED RELEASE / ORAL | | 16 mg | Exact identifier — unii+route 54 equally ranked IID candidates |
| FD&C RED NO. 40 | FD&C RED NO. 40 | WZB9127XOA | SUSPENSION/ DROPS / ORAL | | 1 mg | Exact identifier — unii+route 66 equally ranked IID candidates |
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, FOR SUSPENSION / ORAL | | 65 mg | Exact identifier — unii+route 54 equally ranked IID candidates |